Days Inventory is also known as Days Sales of Inventory (DSI). Insmed's Average Total Inventories for the
three
months ended in Dec. 2023 was $80.6 Mil. Insmed's Cost of Goods Sold for the
three
months ended in Dec. 2023 was $18.4 Mil.
Hence, Insmed's Days Inventory for the
three
months ended in Dec. 2023 was 398.71.
The historical rank and industry rank for Insmed's Days Inventory or its related term are showing as below:
INSM'
s Days Inventory Range Over the Past 10 Years
Min: 266.42 Med: 439.81 Max: 1059.3
Current: 422.77
During the past 13 years, Insmed's highest Days Inventory was 1059.30. The lowest was 266.42. And the median was 439.81.
INSM's Days Inventory is ranked worse than 78.27% of 649
companies
in the Biotechnology industry
Industry Median: 190.88
vs INSM: 422.77
Insmed's Days Inventory
declined
from Dec. 2022 (475.48) to Dec. 2023 (398.71).
Inventory Turnover measures how fast the company turns over its inventory within a year.
Insmed's Inventory Turnover for the
three
months ended in Dec. 2023 was 0.23.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Insmed's Inventory-to-Revenue for the
three
months ended in Dec. 2023 was 0.96.
Insmed Days Inventory Historical Data
The historical data trend for Insmed's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Premium members only.
Insmed Annual Data
Trend
Dec14
Dec15
Dec16
Dec17
Dec18
Dec19
Dec20
Dec21
Dec22
Dec23
Days Inventory
266.42
356.58
481.96
453.32
426.30
Insmed Quarterly Data
Mar19
Jun19
Sep19
Dec19
Mar20
Jun20
Sep20
Dec20
Mar21
Jun21
Sep21
Dec21
Mar22
Jun22
Sep22
Dec22
Mar23
Jun23
Sep23
Dec23
Days Inventory
475.48
465.95
408.76
424.06
398.71
Competitive Comparison
For the Biotechnology subindustry, Insmed's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Insmed Days Inventory Distribution
For the Biotechnology industry and Healthcare sector, Insmed's Days Inventory distribution charts can be found below:
* The bar in red indicates where Insmed's Days Inventory falls into.
Insmed Days Inventory Calculation
Days Inventory indicates the number of days of goods in sales that a company has in the inventory.
Insmed's Days Inventory for the fiscal year that ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Insmed (NAS:INSM) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Insmed's Inventory Turnover for the
three
months ended in Dec. 2023 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Insmed's Inventory to Revenue for the
three
months ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Insmed Days Inventory Related Terms
Thank you for viewing the detailed overview of Insmed's Days Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.
Insmed Inc is a global biopharmaceutical company transforming the lives of patients with serious and rare diseases. The company's first commercial product is ARIKAYCE (amikacin liposome inhalation suspension), approved in the US for the treatment of Mycobacterium Avium Complex (MAC) lung disease as part of a combination antibacterial drug regimen for adult patients with limited or no alternative treatment options. The company's earlier-stage clinical pipeline includes Brensocatib, a novel oral reversible inhibitor of dipeptidyl peptidase 1 with therapeutic potential in non-cystic fibrosis bronchiectasis and other inflammatory diseases; and INS1009, an inhaled formulation of a treprostinil prodrug that may offer a differentiated product profile for pulmonary arterial hypertension.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
INSM has been successfully added to your 